SCHEMBL7301657

SCHEMBL7301657

CC(C)(C)ONC(=O)C1CC(CS(=O)(=O)c2ccc(Oc3ccc(Cl)cn3)cc2)CCO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRB P28702 1/20 0.39
GRIN2B Q13224 1/20 0.35
P2RX3 P56373 9/20 0.35
LIPE Q05469 1/20 0.35
DAGLA Q9Y4D2 1/20 0.34
MMP1 P03956 3/20 0.34
ACACB O00763 2/20 0.34
FAAH O00519 1/20 0.33
ABCB11 O95342 1/20 0.33
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP7 P09237 1/20 0.33
MMP10 P09238 1/20 0.33
MMP9 P14780 1/20 0.33
MMP8 P22894 1/20 0.33
MMP13 P45452 1/20 0.33
MMP14 P50281 1/20 0.33
ADAM17 P78536 1/20 0.33
FPR2 P25090 1/20 0.33
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306490 0.85 RXRB (0.39) RXRBGRIN2BP2RX3LIPEFAAH
SCHEMBL7310773 0.83 MMP1 (0.41) MMP1MMP2MMP3MMP7MMP9
SCHEMBL7307841 0.74 MMP2 (0.43) P2RX3LIPEDAGLAMMP1MMP2
SCHEMBL7302376 0.69 MMP2 (0.50) P2RX3LIPEDAGLAMMP1MMP2
SCHEMBL7303122 0.67 ALDH1A1 (0.34) MMP1MMP2MMP3MMP7MMP9
SCHEMBL7307600 0.65 MMP13 (0.46) MMP1MMP2MMP3MMP7MMP9
SCHEMBL7300208 0.65 MMP13 (0.78) MMP1ABCB11MMP2MMP3MMP7
SCHEMBL8426091 0.64 MMP2 (0.47) MMP1ABCB11MMP2MMP3MMP7
SCHEMBL940743 0.64 PTGS2 (0.57) P2RX3LIPEDAGLASCN9A
SCHEMBL20325535 0.64 LIPE (0.48) LIPEDAGLAMMP1MMP2MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed